首页 > 最新文献

Coronavirus Disease 2019 (COVID-19)最新文献

英文 中文
“Healthcare at its finest”: Patient perspectives on virtual care appointments in primary care “最好的医疗保健”:患者对初级保健中虚拟护理预约的看法
Pub Date : 2022-03-01 DOI: 10.1370/afm.20.s1.2944
Rachelle Ashcroft, B. Ryan, Kavita Mehta, J. Brown, Simon Lam, L. Dolovich, Amélie Boudreault, J. Rayner, J. Grenier, S. Dahrouge, Sally Abudiab, Sandeep Gill, C. Donnelly, J. Alloo, D. Verrilli
Context: COVID-19 led to a rapid uptake of virtual care appointments (telephone and video) in primary care (PC). Decisions on the future of virtual care need to consider patien ts’ experiences. Objective: To understand patients’ experience with virtual care appointments. Study Design: Mixed methods study, presentation focus on qualitative data. A semi-structured interview guide was co-created with patient advisors. A broad recruitment strategy included emailing patient and community organizations, research team network, and social media. Data analyzed using thematic analysis. Participant Eligibility: At least one synchronous virtual encounter in PC since March 2020. Setting: Ontario (Canada) offers universal coverage for PC visits with no co-payment. Results: N=55 interviews were conducted between January 2021 and March 2021. Technology: Telephone was preferred modality. Access: Virtual care was convenient and saved patients’ time and money. Appointment scheduling & booking processes were barriers. Privacy and Confidentiality: No concerns about privacy & confidentiality in patients’ environment, yet participants wanted assurance about privacy & confidentiality in providers’ environm ent. Communication: Providers’ detailed explanations, patients’ health literacy levels, and asynchronous methods of sharing information and documents before and/or after appointments facilitated good experiences. Lack of body-language was a barrier. Therapeutic Relationship: Strong pre-existing relationships facilitated good virtual care experiences. Participants expressed concerns about long-term erosion of relationship when using virtual care. Whole-Person Care: Virtual care facilitated easy inclusion of family members in appointments. However, virtual care appointments were more problem-focused and included less conversation topics outside of specific problem
背景:COVID-19导致初级保健(PC)迅速采用虚拟护理预约(电话和视频)。决定虚拟医疗的未来需要考虑病人的经历。目的:了解虚拟预约护理的患者体验。研究设计:混合方法研究,以定性数据为主。与耐心的顾问共同编写了半结构化的面试指南。广泛的招聘策略包括给患者和社区组织、研究团队网络和社交媒体发电子邮件。数据分析采用专题分析。参与者资格:自2020年3月起在PC上至少进行过一次同步虚拟会议。设置:安大略省(加拿大)提供普遍覆盖的个人电脑访问没有共同支付。结果:在2021年1月至2021年3月期间进行了N=55次访谈。技术:电话是首选的方式。访问:虚拟护理很方便,节省了患者的时间和金钱。预约安排和预订流程是障碍。隐私和保密性:不担心患者环境中的隐私和保密性,但参与者希望确保提供者环境中的隐私和保密性。沟通:提供者的详细解释、患者的健康素养水平以及预约前后共享信息和文件的异步方法促进了良好的体验。缺乏肢体语言是一个障碍。治疗关系:牢固的既存关系促进了良好的虚拟护理体验。参与者表达了使用虚拟护理对长期关系侵蚀的担忧。全人护理:虚拟护理便于家庭成员预约。然而,虚拟护理预约更注重问题,在特定问题之外的谈话话题更少
{"title":"“Healthcare at its finest”: Patient perspectives on virtual care appointments in primary care","authors":"Rachelle Ashcroft, B. Ryan, Kavita Mehta, J. Brown, Simon Lam, L. Dolovich, Amélie Boudreault, J. Rayner, J. Grenier, S. Dahrouge, Sally Abudiab, Sandeep Gill, C. Donnelly, J. Alloo, D. Verrilli","doi":"10.1370/afm.20.s1.2944","DOIUrl":"https://doi.org/10.1370/afm.20.s1.2944","url":null,"abstract":"Context: COVID-19 led to a rapid uptake of virtual care appointments (telephone and video) in primary care (PC). Decisions on the future of virtual care need to consider patien ts’ experiences. Objective: To understand patients’ experience with virtual care appointments. Study Design: Mixed methods study, presentation focus on qualitative data. A semi-structured interview guide was co-created with patient advisors. A broad recruitment strategy included emailing patient and community organizations, research team network, and social media. Data analyzed using thematic analysis. Participant Eligibility: At least one synchronous virtual encounter in PC since March 2020. Setting: Ontario (Canada) offers universal coverage for PC visits with no co-payment. Results: N=55 interviews were conducted between January 2021 and March 2021. Technology: Telephone was preferred modality. Access: Virtual care was convenient and saved patients’ time and money. Appointment scheduling & booking processes were barriers. Privacy and Confidentiality: No concerns about privacy & confidentiality in patients’ environment, yet participants wanted assurance about privacy & confidentiality in providers’ environm ent. Communication: Providers’ detailed explanations, patients’ health literacy levels, and asynchronous methods of sharing information and documents before and/or after appointments facilitated good experiences. Lack of body-language was a barrier. Therapeutic Relationship: Strong pre-existing relationships facilitated good virtual care experiences. Participants expressed concerns about long-term erosion of relationship when using virtual care. Whole-Person Care: Virtual care facilitated easy inclusion of family members in appointments. However, virtual care appointments were more problem-focused and included less conversation topics outside of specific problem","PeriodicalId":10691,"journal":{"name":"Coronavirus Disease 2019 (COVID-19)","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84769431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical Trials of COVID-19 Therapeutics and Vaccines COVID-19疗法和疫苗的临床试验
Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-14
Candan Hizel Perry, H. Ö. Kılgöz, S. Tüzmen
{"title":"Clinical Trials of COVID-19 Therapeutics and Vaccines","authors":"Candan Hizel Perry, H. Ö. Kılgöz, S. Tüzmen","doi":"10.1201/9781003190394-14","DOIUrl":"https://doi.org/10.1201/9781003190394-14","url":null,"abstract":"","PeriodicalId":10691,"journal":{"name":"Coronavirus Disease 2019 (COVID-19)","volume":"85 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79648996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Stem Cell and Exosome-Based Therapy in COVID-19 干细胞和外泌体治疗在COVID-19中的应用
Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-9
S. Kara, A. Sariboyaci
{"title":"Application of Stem Cell and Exosome-Based Therapy in COVID-19","authors":"S. Kara, A. Sariboyaci","doi":"10.1201/9781003190394-9","DOIUrl":"https://doi.org/10.1201/9781003190394-9","url":null,"abstract":"","PeriodicalId":10691,"journal":{"name":"Coronavirus Disease 2019 (COVID-19)","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79739756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug Repurposing and Novel Antiviral Drugs for COVID-19 Management 药物再利用和新型抗病毒药物用于COVID-19管理
Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-7
Shailendra Dwivedi, A. Rawat, A. Ranjan, Ruchika Agrawal, Radhieka Misra, S. Gupta, S. Kishore, S. Misra
{"title":"Drug Repurposing and Novel Antiviral Drugs for COVID-19 Management","authors":"Shailendra Dwivedi, A. Rawat, A. Ranjan, Ruchika Agrawal, Radhieka Misra, S. Gupta, S. Kishore, S. Misra","doi":"10.1201/9781003190394-7","DOIUrl":"https://doi.org/10.1201/9781003190394-7","url":null,"abstract":"","PeriodicalId":10691,"journal":{"name":"Coronavirus Disease 2019 (COVID-19)","volume":"57 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84683078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanomaterials in COVID-19 Drug Development 纳米材料在COVID-19药物开发中的应用
Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-12
A. Aljabali, Ã. Serrano-Aroca, K. Lundstrom, M. Tambuwala
{"title":"Nanomaterials in COVID-19 Drug Development","authors":"A. Aljabali, Ã. Serrano-Aroca, K. Lundstrom, M. Tambuwala","doi":"10.1201/9781003190394-12","DOIUrl":"https://doi.org/10.1201/9781003190394-12","url":null,"abstract":"","PeriodicalId":10691,"journal":{"name":"Coronavirus Disease 2019 (COVID-19)","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81845572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Host and Pathogen-Specific Drug Targets in COVID-19 COVID-19中宿主和病原体特异性药物靶点
Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-10
B. Uhal, David Connolly, Farzaneh Darbeheshti, Y. Zheng, I. Eke, Yutein Chung, L. Samavati
{"title":"Host and Pathogen-Specific Drug Targets in COVID-19","authors":"B. Uhal, David Connolly, Farzaneh Darbeheshti, Y. Zheng, I. Eke, Yutein Chung, L. Samavati","doi":"10.1201/9781003190394-10","DOIUrl":"https://doi.org/10.1201/9781003190394-10","url":null,"abstract":"","PeriodicalId":10691,"journal":{"name":"Coronavirus Disease 2019 (COVID-19)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88605868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention and Control Strategies for the COVID-19 Pandemic 2019冠状病毒病大流行防控策略
Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-4
Isfendiyar Darbaz, G. Morris, S. Tüzmen
{"title":"Prevention and Control Strategies for the COVID-19 Pandemic","authors":"Isfendiyar Darbaz, G. Morris, S. Tüzmen","doi":"10.1201/9781003190394-4","DOIUrl":"https://doi.org/10.1201/9781003190394-4","url":null,"abstract":"","PeriodicalId":10691,"journal":{"name":"Coronavirus Disease 2019 (COVID-19)","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85287998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Convalescent Plasma and Antibody Therapy in COVID-19 COVID-19恢复期血浆和抗体治疗
Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-8
Didem Rıfkı, Eymen Ü. Kılıç, S. Tüzmen
{"title":"Convalescent Plasma and Antibody Therapy in COVID-19","authors":"Didem Rıfkı, Eymen Ü. Kılıç, S. Tüzmen","doi":"10.1201/9781003190394-8","DOIUrl":"https://doi.org/10.1201/9781003190394-8","url":null,"abstract":"","PeriodicalId":10691,"journal":{"name":"Coronavirus Disease 2019 (COVID-19)","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86252641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lessons Learned from COVID-19 and Their Implementations for Future Pandemics 从2019冠状病毒病中吸取的教训及其对未来大流行的实施
Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-15
M. Corredor, D. Barh, K. Lundstrom
{"title":"Lessons Learned from COVID-19 and Their Implementations for Future Pandemics","authors":"M. Corredor, D. Barh, K. Lundstrom","doi":"10.1201/9781003190394-15","DOIUrl":"https://doi.org/10.1201/9781003190394-15","url":null,"abstract":"","PeriodicalId":10691,"journal":{"name":"Coronavirus Disease 2019 (COVID-19)","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88910028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronavirus Epidemics and the Current COVID-19 Pandemic 冠状病毒流行和当前的COVID-19大流行
Pub Date : 2022-02-07 DOI: 10.1201/9781003190394-1
Aparna Bhardwaj, Prateek Kumar, S. K. Kapuganti, V. Uversky, Rajanish Giri
{"title":"Coronavirus Epidemics and the Current COVID-19 Pandemic","authors":"Aparna Bhardwaj, Prateek Kumar, S. K. Kapuganti, V. Uversky, Rajanish Giri","doi":"10.1201/9781003190394-1","DOIUrl":"https://doi.org/10.1201/9781003190394-1","url":null,"abstract":"","PeriodicalId":10691,"journal":{"name":"Coronavirus Disease 2019 (COVID-19)","volume":"189 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74177674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Coronavirus Disease 2019 (COVID-19)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1